{"id":"https://openalex.org/W4409653274","doi":"https://doi.org/10.1111/1756-185x.70225","title":"Tofacitinib Treatment for Primary Sj\u00f6gren's Disease Complicated by Immune Thrombocytopenia: A Case Report","display_name":"Tofacitinib Treatment for Primary Sj\u00f6gren's Disease Complicated by Immune Thrombocytopenia: A Case Report","publication_year":2025,"publication_date":"2025-04-01","ids":{"openalex":"https://openalex.org/W4409653274","doi":"https://doi.org/10.1111/1756-185x.70225","pmid":"https://pubmed.ncbi.nlm.nih.gov/40256907"},"language":"en","primary_location":{"id":"doi:10.1111/1756-185x.70225","doi":"https://doi.org/10.1111/1756-185x.70225","is_oa":false,"landing_page_url":"https://doi.org/10.1111/1756-185x.70225","pdf_url":null,"source":{"id":"https://openalex.org/S169069398","display_name":"International Journal of Rheumatic Diseases","issn_l":"1756-1841","issn":["1756-1841","1756-185X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Rheumatic Diseases","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Jing Ning","orcid":"https://orcid.org/0009-0007-3367-3980","observed_orcids":["https://orcid.org/0009-0007-3367-3980"]},"institutions":[{"id":"https://openalex.org/I4210124809","display_name":"Peking University People's Hospital","ror":"https://ror.org/035adwg89","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210124809"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jing Ning","raw_affiliation_strings":["Department of Rheumatology & Immunology Peking University People's Hospital Beijing China"],"raw_orcid":"https://orcid.org/0009-0007-3367-3980","affiliations":[{"raw_affiliation_string":"Department of Rheumatology & Immunology Peking University People's Hospital Beijing China","institution_ids":["https://openalex.org/I4210124809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004351698","display_name":"Qinghong Liu","orcid":"https://orcid.org/0009-0008-1643-4344","observed_orcids":["https://orcid.org/0009-0008-1643-4344"]},"institutions":[{"id":"https://openalex.org/I4210124809","display_name":"Peking University People's Hospital","ror":"https://ror.org/035adwg89","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210124809"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Qinghong Liu","raw_affiliation_strings":["Department of Rheumatology & Immunology Peking University People's Hospital Beijing China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rheumatology & Immunology Peking University People's Hospital Beijing China","institution_ids":["https://openalex.org/I4210124809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113356204","display_name":"Linger Guan","orcid":"https://orcid.org/0009-0004-5729-8474","observed_orcids":["https://orcid.org/0009-0004-5729-8474"]},"institutions":[{"id":"https://openalex.org/I4210124809","display_name":"Peking University People's Hospital","ror":"https://ror.org/035adwg89","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210124809"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Linger Guan","raw_affiliation_strings":["Department of Rheumatology & Immunology Peking University People's Hospital Beijing China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rheumatology & Immunology Peking University People's Hospital Beijing China","institution_ids":["https://openalex.org/I4210124809"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101681961","display_name":"Jing He","orcid":"https://orcid.org/0000-0002-9881-1025","observed_orcids":["https://orcid.org/0000-0002-9881-1025"]},"institutions":[{"id":"https://openalex.org/I4210124809","display_name":"Peking University People's Hospital","ror":"https://ror.org/035adwg89","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210124809"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Jing He","raw_affiliation_strings":["Department of Rheumatology & Immunology Peking University People's Hospital Beijing China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rheumatology & Immunology Peking University People's Hospital Beijing China","institution_ids":["https://openalex.org/I4210124809"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5101681961"],"corresponding_institution_ids":["https://openalex.org/I4210124809"],"apc_list":{"value":3700,"currency":"USD","value_usd":3700},"apc_paid":null,"fwci":0.497,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.52576207,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"28","issue":"4","first_page":"e70225","last_page":"e70225"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11521","display_name":"Salivary Gland Disorders and Functions","score":0.9775000214576721,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11521","display_name":"Salivary Gland Disorders and Functions","score":0.9775000214576721,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.013399999588727951,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tofacitinib","display_name":"tofacitinib","score":0.9070000052452087},{"id":"https://openalex.org/keywords/primary-sjogren-syndrome","display_name":"primary Sj\u00f6gren's syndrome","score":0.9950000047683716},{"id":"https://openalex.org/keywords/immune-thrombocytopenic-purpura","display_name":"idiopathic thrombocytopenic purpura","score":0.9990000128746033},{"id":"https://openalex.org/keywords/jak-inhibitor-therapy","display_name":"JAK inhibitor therapy","score":0.6919999718666077},{"id":"https://openalex.org/keywords/platelet-count-normalization","display_name":"platelet count normalization","score":0.7590000033378601},{"id":"https://openalex.org/keywords/refractory-itp","display_name":"refractory ITP","score":0.6539999842643738},{"id":"https://openalex.org/keywords/autoimmune-comorbidity","display_name":"autoimmune disease comorbidity","score":0.640999972820282},{"id":"https://openalex.org/keywords/immunosuppressive-therapy","display_name":"immunosuppressive therapy","score":0.746999979019165}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9476316571235657},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.8068161010742188},{"id":"https://openalex.org/C2778886723","wikidata":"https://www.wikidata.org/wiki/Q3530324","display_name":"Tofacitinib","level":3,"score":0.7746456265449524},{"id":"https://openalex.org/C2778720950","wikidata":"https://www.wikidata.org/wiki/Q424972","display_name":"Prednisone","level":2,"score":0.763084888458252},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.7595303654670715},{"id":"https://openalex.org/C2909675724","wikidata":"https://www.wikidata.org/wiki/Q411648","display_name":"Tacrolimus","level":3,"score":0.6036263108253479},{"id":"https://openalex.org/C2776760755","wikidata":"https://www.wikidata.org/wiki/Q18939","display_name":"Azathioprine","level":3,"score":0.504313588142395},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.44851356744766235},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.43658357858657837},{"id":"https://openalex.org/C2779075594","wikidata":"https://www.wikidata.org/wiki/Q8084905","display_name":"Autoimmune disease","level":3,"score":0.4232703745365143},{"id":"https://openalex.org/C2909935303","wikidata":"https://www.wikidata.org/wiki/Q420553","display_name":"Mycophenolate","level":3,"score":0.41880857944488525},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.35791265964508057},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3104432225227356},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.19735094904899597},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.13362857699394226},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.13325417041778564}],"mesh":[{"descriptor_ui":"D000075242","descriptor_name":"Janus Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010976","descriptor_name":"Platelet Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012859","descriptor_name":"Sjogren's Syndrome","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D012859","descriptor_name":"Sjogren's Syndrome","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D012859","descriptor_name":"Sjogren's Syndrome","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D012859","descriptor_name":"Sjogren's Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012859","descriptor_name":"Sjogren's Syndrome","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D016553","descriptor_name":"Purpura, Thrombocytopenic, Idiopathic","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D016553","descriptor_name":"Purpura, Thrombocytopenic, Idiopathic","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D016553","descriptor_name":"Purpura, Thrombocytopenic, Idiopathic","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D016553","descriptor_name":"Purpura, Thrombocytopenic, Idiopathic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016553","descriptor_name":"Purpura, Thrombocytopenic, Idiopathic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/1756-185x.70225","doi":"https://doi.org/10.1111/1756-185x.70225","is_oa":false,"landing_page_url":"https://doi.org/10.1111/1756-185x.70225","pdf_url":null,"source":{"id":"https://openalex.org/S169069398","display_name":"International Journal of Rheumatic Diseases","issn_l":"1756-1841","issn":["1756-1841","1756-185X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Rheumatic Diseases","raw_type":"journal-article"},{"id":"pmid:40256907","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40256907","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of rheumatic diseases","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320321001","display_name":"National Natural Science Foundation of China","ror":"https://ror.org/01h0zpd94"},{"id":"https://openalex.org/F4320335777","display_name":"National Key Research and Development Program of China","ror":null}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W2082707670","https://openalex.org/W2095522674","https://openalex.org/W2982538063","https://openalex.org/W3017209589","https://openalex.org/W3082888964","https://openalex.org/W4225986266","https://openalex.org/W4379802385","https://openalex.org/W4385359012","https://openalex.org/W4388837382","https://openalex.org/W4400447510","https://openalex.org/W4400454635","https://openalex.org/W4402366403","https://openalex.org/W4402454544","https://openalex.org/W4403940572","https://openalex.org/W4406914199"],"related_works":["https://openalex.org/W4400121627","https://openalex.org/W4399590611","https://openalex.org/W4296638383","https://openalex.org/W7133561356","https://openalex.org/W4385359012","https://openalex.org/W4365138933","https://openalex.org/W3017209589","https://openalex.org/W2018501430","https://openalex.org/W2007034198","https://openalex.org/W2737655059"],"abstract_inverted_index":{"Primary":[0],"Sj\u00f6gren's":[1],"disease":[2],"(SjD)":[3],"is":[4,42],"a":[5,52,84],"systemic":[6],"autoimmune":[7],"disorder":[8],"that":[9],"primarily":[10],"affects":[11],"the":[12,49,107,127],"salivary":[13],"and":[14,60,75,104],"lacrimal":[15],"glands.":[16],"It":[17],"has":[18,56,79,113],"been":[19,80],"associated":[20],"with":[21,38,40,69],"immune":[22],"thrombocytopenia":[23],"(ITP)":[24],"in":[25,132],"about":[26],"12%":[27],"of":[28,51,86,110,130],"cases.":[29],"Current":[30],"research":[31],"into":[32,94],"new":[33],"treatment":[34,68,96],"strategies":[35],"for":[36,62,106,117,136],"patients":[37,137],"SjD":[39,59],"ITP":[41,61],"limited.":[43],"In":[44],"this":[45,115],"report,":[46],"we":[47],"present":[48],"case":[50,125],"38-year-old":[53],"woman":[54],"who":[55,138],"suffered":[57],"from":[58],"over":[63],"20":[64],"years.":[65],"Despite":[66],"undergoing":[67],"prednisone,":[70],"mycophenolate":[71],"mofetil,":[72],"rituximab,":[73],"tacrolimus,":[74],"cyclosporine":[76],"A,":[77],"she":[78],"unable":[81],"to":[82,100,146],"achieve":[83],"normalization":[85],"her":[87,95],"platelet":[88,102],"count.":[89],"Eventually,":[90],"tofacitinib":[91,131],"was":[92],"introduced":[93],"plan,":[97],"which":[98],"led":[99],"stable":[101],"counts":[103],"allowed":[105],"complete":[108],"discontinuation":[109],"prednisone.":[111],"She":[112],"maintained":[114],"stability":[116],"more":[118],"than":[119],"2":[120],"years":[121],"so":[122],"far.":[123],"This":[124],"underscores":[126],"potential":[128],"role":[129],"managing":[133],"SjD-ITP,":[134],"particularly":[135],"do":[139],"not":[140],"respond":[141],"adequately":[142],"or":[143],"are":[144],"intolerant":[145],"conventional":[147],"immunosuppressive":[148],"therapies.":[149]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2025-04-22T00:00:00"}